首页 | 本学科首页   官方微博 | 高级检索  
检索        

吴茱萸次碱的研究进展
引用本文:余奇,郭澄,程泽能.吴茱萸次碱的研究进展[J].药学实践杂志,2007,25(6):353-357.
作者姓名:余奇  郭澄  程泽能
作者单位:1. 上海交通大学附属第六人民医院药剂科,上海,200233;中南大学药学院药物动力学研究所,湖南,长沙,410013
2. 上海交通大学附属第六人民医院药剂科,上海,200233
3. 中南大学药学院药物动力学研究所,湖南,长沙,410013
摘    要:吴茱萸次碱是中药吴茱萸中的主要有效成分,本文介绍了近十余年来国内外对吴茱萸次碱的研究进展,包括合成、对药物代谢酶的影响、代谢机制和药理作用等。

关 键 词:吴茱萸次碱  合成  细胞色素P450  降钙素基因相关肽  药理作用
文章编号:1006-0111(2007)06-0353-05
收稿时间:2007-02-01
修稿时间:2007年2月1日

Current advances in the study on rutaecarpine
YU Qi,GUO Cheng and CHENG Ze-neng.Current advances in the study on rutaecarpine[J].The Journal of Pharmaceutical Practice,2007,25(6):353-357.
Authors:YU Qi  GUO Cheng and CHENG Ze-neng
Institution:Department of Pharmacy,Shanghai Sixth People's Hospital,Shanghai JiaoTong University,Shanghai 200233,China;Department of Pharmacokinetics,School of Pharmaceutical Sciences,Central South University,Changsha 410013,China.;Department of Pharmacy,Shanghai Sixth People's Hospital,Shanghai JiaoTong University,Shanghai 200233,China;Department of Pharmacokinetics,School of Pharmaceutical Sciences,Central South University,Changsha 410013,China.;Department of Pharmacy,Shanghai Sixth People's Hospital,Shanghai JiaoTong University,Shanghai 200233,China;Department of Pharmacokinetics,School of Pharmaceutical Sciences,Central South University,Changsha 410013,China.;Department of Pharmacology,School of Pharmacy,Second Military Medical University,Shanghai 200433,China;Department of Epidemiology Second Military Medical University,Shanghai 200433,China;3.The 411th Hospital of PLA,Shanghai 200433,China;Department of Pharmacology,School of Pharmacy,Second Military Medical University,Shanghai 200433,China;Department of Epidemiology Second Military Medical University,Shanghai 200433,China;3.The 411th Hospital of PLA,Shanghai 200433,China;Department of Pharmacology,School of Pharmacy,Second Military Medical University,Shanghai 200433,China;Department of Epidemiology Second Military Medical University,Shanghai 200433,China;3.The 411th Hospital of PLA,Shanghai 200433,China;Department of Pharmacology,School of Pharmacy,Second Military Medical University,Shanghai 200433,China;Department of Epidemiology Second Military Medical University,Shanghai 200433,China;3.The 411th Hospital of PLA,Shanghai 200433,China;Department of Pharmacology,School of Pharmacy,Second Military Medical University,Shanghai 200433,China;Department of Epidemiology Second Military Medical University,Shanghai 200433,China;3.The 411th Hospital of PLA,Shanghai 200433,China;Department of Pharmacology,School of Pharmacy,Second Military Medical University,Shanghai 200433,China;Department of Epidemiology Second Military Medical University,Shanghai 200433,China;3.The 411th Hospital of PLA,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Department of Medicinal Chemistry,Pharmacy School,Second Military Medical University,Shanghai 200433,China;Institute of Pharmacology,North Sichuan Medical College,Nanchong 637007,China;Institute of Pharmacology,North Sichuan Medical College,Nanchong 637007,China;Institute of Pharmacology,North Sichuan Medical College,Nanchong 637007,China;Institute of Pharmacology,North Sichuan Medical College,Nanchong 637007,China;Institute of Pharmacology,North Sichuan Medical College,Nanchong 637007,China;Institute of Pharmacology,North Sichuan Medical College,Nanchong 637007,China;Department of Pharmacy,No.451 Hospital of PLA,Xi'an 710000,China;Department of Pharmacy,General Hospital of Lanzhou Command of PLA,Lanzhou 730050,China;Department of Pharmacy,No.451 Hospital of PLA,Xi'an 710000,China;Department of Pharmacy,General Hospital of Lanzhou Command of PLA,Lanzhou 730050,China;Changxing People's Hospital of Zhejiang Province,Changxing 313100 China;Central Hospital of Huzhou of Zhejiang Province,Huzhou 313000,China;Changxing People's Hospital of Zhejiang Province,Changxing 313100 China;Central Hospital of Huzhou of Zhejiang Province,Huzhou 313000,China;Dept.of Pharmacy,General Hospital of Beijing Military Region,Beijing100700, China;Dept.of Pharmacy,General Hospital of Beijing Military Region,Beijing100700, China;Dept.of Pharmacy,General Hospital of Beijing Military Region,Beijing100700, China;Dept.of Pharmacy,General Hospital of Beijing Military Region,Beijing100700, China;Dept.of Pharmacy,General Hospital of Beijing Military Region,Beijing100700, China;Zhejiang Institute for Drug Control,Hangzhou 310004,China;Zhejiang Institute for Drug Control,Hangzhou 310004,China;Department of Pharmacy,Tongde Hospital of Zhejiang Province,Hangzhou310012,China;Second bureau of drugs,general hospital of Chinese PLA,Beijing 100853,China;3rd Hospital of PLA,Baoji 721004,China;3rd Hospital of PLA,Baoji 721004,China;3rd Hospital of PLA,Baoji 721004,China;3rd Hospital of PLA,Baoji 721004,China;Department Pharmacy,General Hospital of PLA,Beijing 100853,China;Department Pharmacy,General Hospital of PLA,Beijing 100853,China;No.303 Hospital of PLA,Nanning 530021,China
Abstract:The rutaecarpine is an effective component from Evodia rutaecarpa(Juss.) Benth.Current advances in the study of rutaecarpine is reviewed,including synthesize,effects on metabolizing enzyme,metabolic mechanism, pharmacological activity,etc.
Keywords:rutaecarpine  synthesize  CYP450  CGRP  pharmacological activity  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号